RushA, MatzkeL, CooperS, et al.Research perspective on utilizing and valuing tumor biobanks. Biopreserv Biobank, 2019; 17(3):219–229; doi: 10.1089/bio.2018.0099
3.
GrizzleWE, BledsoeMJ, DiffalhaS, et al.The utilization of biospecimens: Impact of the choice of biobanking model. Biopreserv Biobank, 2019; 17(3):230–242; doi: 10.1089/bio.2019.0008
4.
TarlingTE, ByrneJA, WatsonPH. The availability of human biospecimens to support biomarker research. Biomark Insights, 2022; 17:11772719221091750; doi: 10.1177/11772719221091750
5.
MeredithAJ, SlottyA, MatzkeL, et al.A model to estimate frozen tissue collection targets in biobanks to support cancer research. Biopreserv Biobank, 2015; 13(5):356–362; doi: 10.1089/bio.2014.0081
6.
RushA, ByrneJA, WatsonPH. Guideline on valuation of research biospecimen collections. Biopreserv Biobank, 2025; doi: 10.1089/bio.2024.0159
7.
El IdrissiI, PiquardV, FransmanW, et al.A quantitative tool for culling collections of human specimens; proof of concept. Biopreserv Biobank, 2025; doi: 10.1177/19475535251362092
8.
KesslerJA, JohnsonTM, HendersonMK. The development of the biobank collections valuator as an automated tool to determine the noneconomic value of sample collections. Biopreserv Biobank, 2025; doi: 10.1177/19475535251374854